Gene · 814
Papers1,734
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,734
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of BDNF-TrkB signaling in the improvement of motor function and neuroplasticity after ischemic stroke in rats by transcranial direct current stimulation. | Brain Res Bull | 2025 | 39662631 | PubTator, text mining | PubMed |
| Convergence on CaMK4: A Key Modulator of Autism-Associated Signaling Pathways in Neurons. | Biol Psychiatry | 2025 | 39442785 | PubTator, text mining | PubMed |
| GlyT1 inhibition promotes neuroprotection in the middle cerebral artery occlusion model through the activation of GluN2A-containing NMDAR. | Exp Neurol | 2025 | 39424040 | PubTator, text mining | PubMed |
| Role of sodium-dependent vitamin C transporter 2 in human periodontal ligament fibroblasts. | J Periodontal Res | 2025 | 39225294 | PubTator, text mining | PubMed |
| Nanodomain cAMP signaling in cardiac pathophysiology: potential for developing targeted therapeutic interventions. | Physiol Rev | 2025 | 39115424 | PubTator, text mining | PubMed |
| Research advances on CaMKs-mediated neurodevelopmental injury. | Arch Toxicol | 2024 | 39292234 | PubTator, text mining | PubMed |
| TIPRL Regulates Stemness and Survival in Lung Cancer Stem Cells through CaMKK2-CaMK4-CREB Feedback Loop Activation. | Adv Sci (Weinh) | 2024 | 39076120 | PubTator, text mining | PubMed |
| Deciphering Immune Responses to Immunization via Transcriptional Analysis: A Narrative Review of the Current Evidence towards Personalized Vaccination Strategies. | Int J Mol Sci | 2024 | 39000206 | PubTator, text mining | PubMed |
| Feasibility of Using a Type I IFN-Based Non-Animal Approach to Predict Vaccine Efficacy and Safety Profiles. | Vaccines (Basel) | 2024 | 38932312 | PubTator, text mining | PubMed |
| CaMKIV-Mediated Phosphorylation Inactivates Freud-1/CC2D1A Repression for Calcium-Dependent 5-HT1A Receptor Gene Induction. | Int J Mol Sci | 2024 | 38892382 | PubTator, text mining | PubMed |
| Myricetin ameliorates the severity of pancreatitis in mice by regulating cathepsin B activity and inflammatory cytokine production. | Int Immunopharmacol | 2024 | 38823179 | PubTator, text mining | PubMed |
| The enhanced energy metabolism in the tumor margin mediated by RRAD promotes the progression of oral squamous cell carcinoma. | Cell Death Dis | 2024 | 38811531 | PubTator, text mining | PubMed |
| CaMK4: Structure, physiological functions, and therapeutic potential. | Biochem Pharmacol | 2024 | 38615920 | PubTator, text mining | PubMed |
| Corrigendum: Genistein protects hippocampal neurons against injury by regulating calcium/calmodulin dependent protein kinase IV protein levels in Alzheimer's disease model rats. | Neural Regen Res | 2024 | 38595284 | PubTator, text mining | PubMed |
| Unique transcriptional signatures correlate with behavioral and psychological symptom domains in Alzheimer's disease. | Transl Psychiatry | 2024 | 38575567 | PubTator, text mining | PubMed |
| miR-129-5p inhibits anchorage-independent growth through silencing of ACTN1 and the ELK4/c-FOS axis in HPV-transformed keratinocytes. | J Med Virol | 2024 | 38566572 | PubTator, text mining | PubMed |
| Understanding the pathogenic significance of altered calcium-calmodulin signaling in T cells in autoimmune diseases. | Clin Immunol | 2024 | 38460894 | PubTator, text mining | PubMed |
| Unraveling the connection between Hashimoto's Thyroiditis and non-alcoholic fatty liver disease: exploring the role of CD4+central memory T cells through integrated genetic approaches. | Endocrine | 2024 | 38400881 | PubTator, text mining | PubMed |
| Nuclear Binding Protein 2/Nesfatin-1 Affects Trophoblast Cell Fusion during Placental Development via the EGFR-PLCG1-CAMK4 Pathway. | Int J Mol Sci | 2024 | 38339201 | PubTator, text mining | PubMed |
| The Traf2 and NcK interacting kinase inhibitor NCB-0846 suppresses seizure activity involving the decrease of GRIA1. | Genes Dis | 2024 | 38292191 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/814/papers?page=3